The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neutrophil to lymphocyte ratio as predictive of prolonged progression free survival (PFS) and overall survival (OS) in patients with metastatic non-small cell lung cancer (NSCLC) treated with second-line PD-1 immune checkpoint inhibitors.
 
Stephanie Labomascus
No Relationships to Disclose
 
Ibtihaj Fughhi
No Relationships to Disclose
 
Philip Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; Merck; Pfizer; Roche/Genentech; Trovagene
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - No disclosures
Expert Testimony - No disclosures
Travel, Accommodations, Expenses - No disclosures
Other Relationship - No disclosures
 
Mary J. Fidler
Consulting or Advisory Role - Abbvie; Abbvie (I); AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech
Speakers' Bureau - Celgene; Genentech; Merck
 
Jeffrey Allen Borgia
No Relationships to Disclose
 
Sanjib Basu
No Relationships to Disclose
 
Matthew A Hoch
No Relationships to Disclose
 
Marta Batus
No Relationships to Disclose